Recently, researchers from Tsinghua University, Peking University, Institute of pathogen biology and Changping Laboratory of China Academy of Medical Sciences jointly developed the public space New Coronavirus monitoring system for bioaerosols and have been successfully applied in Beijing Winter Olympic test competition. The system can collect and detect biological aerosols in the air, and the sensitivity is 10 times higher than that of conventional methods. During the Beijing Winter Olympic Games, aerosol collectors are expected to be arranged in many venues of the Winter Olympic Games.
The number of confirmed cases of overseas covid-19 soared rapidly. On January 14, 2022, the number of confirmed cases worldwide in a single day reached 3.12 million, about four times that of the same period last year. At present, European and American data show that Omicron variant has become the mainstream strain. The number of confirmed cases has surged, and there is a strong demand for covid-19 detection. The overseas one-day nucleic acid detection capacity can not fully meet the existing detection needs. China’s covid-19 kit will usher in the export peak, and relevant enterprises with export capacity such as nucleic acid reagent and antigen kit are expected to achieve performance explosion.
According to the theme database of financial Associated Press, among the relevant listed companies:
Guangzhou Wondfo Biotech Co.Ltd(300482) successfully developed six covid-19 detection products based on immune colloidal gold technology platform, immunofluorescence technology platform and molecular diagnosis technology platform. The full-automatic immunofluorescence detection analyzer adopts puncture sampling, which can avoid aerosol generated during sample centrifugation.
Beijing Zijing biological, indirectly controlled by Zhejiang Xianju Pharmaceutical Co.Ltd(002332) , participates in the public space bioaerosol covid-19 virus detection project and produces integrated nucleic acid detection instruments and reagent consumables.
